PATENT CLAIM ANALYSIS

Application Number: 16033446
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "387000"]

Abstract:
The invention relates to 1,3-diaza-spiro-[3.4]-octane derivatives, their preparation and use in medicine, particularly in various neurological disorders, including but not limited to pain, neurodegenerative disorders, neuroinflammatory disorders, neuropsychiatric disorders, substance abuse/dependence.

Claim (Index 33):
The compound according to  claim 1 , wherein, R 5  means \u2014H.

Metadata:
- Claim Count in Document: 57.0
- Percentile: 95.0
- Lexical Diversity: 1.34375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15417953', '15969907', '15403741', '13483170', '12281317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7308672025763422
- 35 USC 102 Novelty (BERT): 0.5395598344995524
- Combined Prediction Score: 0.7117364657686632
- Mean Citation Score: 333.198664
- Max Citation Score: 350.52203
- Similarity Product: 216.30300808397888

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test